The Indianapolis-based company received U.S. regulatory approval last week for its second medicine in 18 months in what it ...

Sept 19 (Reuters) - For Jessica Lescault there is no question that her 6-year old English bulldog "Moose" deserves cutting-edge biotechnology cancer treatment as much as any human patient. "Pets are ...

Cytopoint targets and neutralizes canine interleukin-31 (cIL-31), a key protein involved in triggering itch in dogs. Administered by injection once monthly, Cytopoint provides fast, long-lasting ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Department of Agriculture (USDA) has granted the company a license for CYTOPOINT™, the first monoclonal antibody ...

Seasonal allergies affect approximately 10-15% of the dog and cat population, causing discomfort and distress to our beloved pets. 2 Spot Pet Insurance's data team examined claims involving Cytopoint ...